Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

TPEX/4126 stock hub

TPEX/4126 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4126is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.8B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4126

In the news

Latest news · TPEX/4126

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E14.9

P25 14.4P50 18P75 31.9

ROE11.5

P25 -16.2P50 0.3P75 9.8

ROIC16.7

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4126 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

242

Groups with data

Currency

TWD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	812
Employees Change	10%
Employees Change Percent	1.25
Enterprise value	TWD 5B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	TW0004126008
Last refreshed	2026-05-10
Market cap	TWD 5.8B
Price	TWD 79.8
Price currency	TWD
Rev Per Employee	2,934,651.48x
Sector	Healthcare
Sic	3841
Symbol	tpex/4126
Website	https://www.pahsco.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.12%
EV Earnings	14.07x
EV/EBIT	10.92x
EV/EBITDA	8.5x
EV/FCF	10.52x
EV/Sales	2.09x
FCF yield	8.19%
P/B ratio	1.89x
P/E ratio	14.85x
P/S ratio	2.43x
PE Ratio10 Y	16.6x
PE Ratio3 Y	15.47x
PE Ratio5 Y	15.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.18%
EBITDA Margin	24.21%
FCF margin	19.92%
Gross margin	30.08%
Gross Profit	TWD 716.8M
Gross Profit Growth	-1.07%
Gross Profit Growth Q	-23.54%
Gross Profit Growth3 Y	7.91%
Gross Profit Growth5 Y	1.73%
Net Income	TWD 354.6M
Net Income Growth	-14.51%
Net Income Growth Q	-18.61%
Net Income Growth Years	0%
Net Income Growth3 Y	4.93%
Net Income Growth5 Y	3.1%
Pretax Margin	18.52%
Profit Margin	14.88%
Profit Per Employee	TWD 436,723
Profitable Years	16
ROA	7.16
Roa5y	7
ROCE	13.06
ROE	11.54
Roe5y	14.08
ROIC	16.74
Roic5y	14.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.96%
Cagr15y	2.97%
Cagr1y	-7.37%
Cagr20y	16.16%
Cagr3y	1.65%
Cagr5y	7.87%
Div CAGR10	8.2%
Div CAGR3	5.98%
Div CAGR5	3.55%
EPS Growth	-14.52
EPS Growth Q	-18.34
EPS Growth Years	0
EPS Growth3 Y	4.9
EPS Growth5 Y	3.09
FCF Growth	0.8%
FCF Growth Q	1.24%
FCF Growth3 Y	5.28%
FCF Growth5 Y	-1.02%
OCF Growth	7.29%
OCF Growth Q	3.62%
OCF Growth10 Y	4.74%
OCF Growth3 Y	7.89%
OCF Growth5 Y	-1.01%
Revenue Growth	2.59x
Revenue Growth Q	-9.83x
Revenue Growth Years	4x
Revenue Growth3 Y	3.26x
Revenue Growth5 Y	2.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.6
Assets	TWD 4B
Cash	TWD 1.2B
Current Assets	TWD 1.8B
Current Liabilities	TWD 522.3M
Debt	TWD 426.4M
Debt EBITDA	TWD 0.73
Debt Equity	TWD 0.14
Debt FCF	TWD 0.9
Equity	TWD 3.1B
Interest Coverage	76.48
Liabilities	TWD 905.5M
Long Term Assets	TWD 2.2B
Long Term Liabilities	TWD 383.2M
Net Cash	TWD 802.8M
Net Cash By Market Cap	TWD 13.86
Net Cash Growth	8.89%
Net Debt EBITDA	TWD -1.39
Net Debt Equity	TWD -0.26
Net Debt FCF	TWD -1.69
Tangible Book Value	TWD 3.1B
Tangible Book Value Per Share	TWD 29.34
WACC	4.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.99
Inventory Turnover	4.65
Net Working Capital	TWD 208.4M
Quick ratio	3.13
Working Capital	TWD 1.4B
Working Capital Turnover	TWD 1.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.07%
Dividend Growth	4.17%
Dividend Growth Years	2%
Dividend per share	TWD 4.5
Dividend Years	21
Dividend Yield	5.64%
Ex Div Date	2025-07-03
Last Dividend	TWD 5
Payout Frequency	Annual
Payout Ratio	102.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	47.5%
1Y total return	-7.37%
200-day SMA	85.69
3Y total return	5.04%
50-day SMA	80.33
50-day SMA vs 200-day SMA	50under200
5Y total return	46.05%
All Time High	113.7
All Time High Change	-29.79%
All Time High Date	2016-05-30
All Time Low	5.12
All Time Low Change	1,460.12%
All Time Low Date	2004-08-24
ATR	0.79
Beta	0.12
Beta1y	0.09
Beta2y	0.07
Ch YTD	-6.34
High	80.7
High52	96.8
High52 Date	2025-06-27
High52ch	-17.56%
Low	79.6
Low52	78
Low52 Date	2026-04-27
Low52ch	2.31%
Ma50ch	-0.66%
Price vs 200-day SMA	-6.87%
RSI	48.73
RSI Monthly	38.13
RSI Weekly	33.76
Sharpe ratio	-1.08x
Sortino ratio	-0.97
Total Return	5.57%
Tr YTD	-6.34
Tr15y	55.06%
Tr1m	-0.87%
Tr1w	0.63%
Tr3m	-0.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 457.1M
Operating Income Growth	-3.35
Operating Income Growth Q	-30.08
Operating Income Growth3 Y	10.12
Operating Income Growth5 Y	1.43
Operating margin	19.18

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,951,062%
Net Borrowing	-11,288,000
Shares Insiders	9.12%
Shares Institutions	6.88%
Shares Out	72,599,802
Shares Qo Q	0.57%
Shares Yo Y	0.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 474.6M
Average Volume	47,077.75x
Bv Per Share	29.41
CAPEX	TWD -77.6M
Ch10y	-6.84
Ch15y	-17.11
Ch1m	-0.87
Ch1w	0.63
Ch1y	-12.21
Ch20y	838.6
Ch3m	-0.25
Ch3y	-10.03
Ch5y	10.22
Ch6m	-9.73
Change	-0.13%
Change From Open	-1.12
Close	79.9
Days Gap	1
Depreciation Amortization	119,103,000
Dollar Volume	1,580,279.4
Earnings Date	2026-05-14
EBIT	TWD 457.1M
EBITDA	TWD 576.9M
EPS	TWD 5.37
F Score	5
FCF	TWD 474.6M
FCF EV Yield	9.51x
FCF Per Share	TWD 6.54
Financing CF	-375,298,000
Fiscal Year End	December
Founded	1,977
Graham Number	59.62087
Graham Upside	-25.29
Income Tax	TWD 86.6M
Investing CF	-198,757,000
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Date	2020-08-03
Last Split Type	Forward
Lynch Fair Value	TWD 26.86
Lynch Upside	-66.34
Ma150	84.2
Ma150ch	-5.22%
Ma20	79.82
Ma20ch	-0.02%
Net CF	-43,207,000
Next Earnings Date	2026-05-14
Open	80.7
P FCF Ratio	12.21
P OCF Ratio	10.49
Payment Date	2025-08-01
Position In Range	18.18
Ppne	1,974,120,000
Price Date	2026-05-08
Price EBITDA	TWD 10.04
Ptbv Ratio	1.89
Relative Volume	0.4x
Revenue	2,382,937,000x
Tax By Revenue	3.63x
Tax Rate	19.63%
Tr20y	1,900.42%
Tr6m	-9.73%
Volume	19,803

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4126 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.6%

$4.50 annual per share

Payout ratio

+102.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+3.5%

2 consecutive years of growth

Total shareholder yield

+5.6%

Next ex-dividend date: 2025-07-03

Performance

TPEX/4126 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4126?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.9%

Share of float held by funds and institutions

Insider ownership

+9.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

TPEX/4126 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.7

Neutral momentum band

Price vs 200-day MA

-6.9%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

-1.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4126

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4126 stock rating?

tpex/4126 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4126 analysis?

The full report lives at /stocks/tpex/4126/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4126?

The latest report frames tpex/4126 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4126 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.